Tanager Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805K | Buy |
4,338
+273
| +7% | +$50.7K | 0.1% | 58 |
|
|
2025
Q1 | $852K | Buy |
4,065
+558
| +16% | +$117K | 0.11% | 51 |
|
|
2024
Q4 | $623K | Buy |
3,507
+596
| +20% | +$106K | 0.08% | 57 |
|
|
2024
Q3 | $575K | Sell |
2,911
-18
| -0.6% | -$3.56K | 0.08% | 59 |
|
|
2024
Q2 | $502K | Hold |
2,929
| – | – | 0.07% | 58 |
|
|
2024
Q1 | $533K | Buy |
2,929
+646
| +28% | +$118K | 0.09% | 54 |
|
|
2023
Q4 | $354K | Sell |
2,283
-378
| -14% | -$58.6K | 0.06% | 63 |
|
|
2023
Q3 | $397K | Buy |
2,661
+40
| +2% | +$5.96K | 0.08% | 54 |
|
|
2023
Q2 | $353K | Buy |
2,621
+102
| +4% | +$13.7K | 0.08% | 61 |
|
|
2023
Q1 | $401K | Buy |
2,519
+245
| +11% | +$39K | 0.1% | 52 |
|
|
2022
Q4 | $368K | Buy |
2,274
+274
| +14% | +$44.3K | 0.1% | 52 |
|
|
2022
Q3 | $268K | Hold |
2,000
| – | – | 0.21% | 34 |
|
|
2022
Q2 | $306K | Hold |
2,000
| – | – | 0.25% | 30 |
|
|
2022
Q1 | $324K | Hold |
2,000
| – | – | 0.24% | 30 |
|
|
2021
Q4 | $271K | Buy |
+2,000
| New | +$271K | 0.2% | 34 |
|